Myelitis, Transverse
Inflammation of a transverse portion of the spinal cord characterized by acute or subacute segmental demyelination or necrosis. The condition may occur sporadically, follow an infection or vaccination, or present as a paraneoplastic syndrome (see also ENCEPHALOMYELITIS, ACUTE DISSEMINATED). Clinical manifestations include motor weakness, sensory loss, and incontinence. (Adams et al., Principles of Neurology, 6th ed, pp1242-6)
Subtype terms (1)
More specific conditions that are subtypes of Myelitis, Transverse in the MeSH hierarchy.
- Neuromyelitis Optica
65 drugs (35 approved, 30 experimental)
Drugs by status
Phase 4 trials (2)
Phase 3 trials (2)
Phase 2 trials (2)
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (12)
Organization Involved with Phase 2 Indications (3)
Organization Involved with Phase 1 Indications (1)